BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34829543)

  • 1. Oxidative Stress in Preterm Newborns.
    Lembo C; Buonocore G; Perrone S
    Antioxidants (Basel); 2021 Oct; 10(11):. PubMed ID: 34829543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.
    Suresh GK; Davis JM; Soll RF
    Cochrane Database Syst Rev; 2001; 2001(1):CD001968. PubMed ID: 11279743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress Related Diseases in Newborns.
    Ozsurekci Y; Aykac K
    Oxid Med Cell Longev; 2016; 2016():2768365. PubMed ID: 27403229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxidative stress after preterm birth: origins, biomarkers, and possible therapeutic approaches].
    Yzydorczyk C; Mitanchez D; Buffat C; Ligi I; Grandvuillemin I; Boubred F; Simeoni U
    Arch Pediatr; 2015 Oct; 22(10):1047-55. PubMed ID: 26143998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside.
    Perrone S; Santacroce A; Longini M; Proietti F; Bazzini F; Buonocore G
    Oxid Med Cell Longev; 2018; 2018():7483062. PubMed ID: 30140369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal and Postnatal Sequelae of Oxidative Stress in Preterm Infants: A Narrative Review Targeting Pathophysiological Mechanisms.
    Martini S; Aceti A; Della Gatta AN; Beghetti I; Marsico C; Pilu G; Corvaglia L
    Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chorioamnionitis and neonatal morbidity].
    Rocha G; Proença E; Quintas C; Rodrigues T; Guimarães H
    Acta Med Port; 2006; 19(3):207-12. PubMed ID: 17234081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early identification of the risk for free radical-related diseases in preterm newborns.
    Perrone S; Tataranno ML; Negro S; Longini M; Marzocchi B; Proietti F; Iacoponi F; Capitani S; Buonocore G
    Early Hum Dev; 2010 Apr; 86(4):241-4. PubMed ID: 20466493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent ductus arteriosus and oxidative stress in preterm infants: a narrative review.
    Dani C; Pratesi S
    Transl Pediatr; 2020 Dec; 9(6):835-839. PubMed ID: 33457306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
    Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
    Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal diseases and oxidative stress in premature infants: an integrative review.
    de Almeida VO; Pereira RA; Amantéa SL; Rhoden CR; Colvero MO
    J Pediatr (Rio J); 2022; 98(5):455-462. PubMed ID: 34953780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do survival and morbidity of very-low-birth-weight infants vary according to the primary pregnancy complication that results in preterm delivery?
    Wolf EJ; Vintzileos AM; Rosenkrantz TS; Rodis JF; Salafia CM; Pezzullo JG
    Am J Obstet Gynecol; 1993 Nov; 169(5):1233-9. PubMed ID: 8238190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future applications of antioxidants in premature infants.
    Lee JW; Davis JM
    Curr Opin Pediatr; 2011 Apr; 23(2):161-6. PubMed ID: 21150443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radicals and diseases in premature infants.
    O'Donovan DJ; Fernandes CJ
    Antioxid Redox Signal; 2004 Feb; 6(1):169-76. PubMed ID: 14713348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.
    Hammers AL; Sanchez-Ramos L; Kaunitz AM
    Am J Obstet Gynecol; 2015 Apr; 212(4):505.e1-13. PubMed ID: 25448524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.